Form 4: Richard C Henriques Jr. Acquires 22,000 Stock Options in Cabaletta Bio, Inc.

Director Richard C Henriques Jr. acquired 22,000 stock options in Cabaletta Bio, Inc. on June 3, 2024, according to a Form 4 filing.

Summary

• Richard C Henriques Jr., a director of Cabaletta Bio, Inc., filed a Form 4 indicating a change in beneficial ownership.
• On June 3, 2024, Henriques acquired 22,000 stock options with an exercise price of $10.01.
• These options vest fully on the earlier of June 3, 2025, or the date of the next annual meeting of the Corporation's stockholders.
• Following the transaction, Henriques directly owns 22,000 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director. While insider ownership can be seen as positive, this is a routine grant.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's increased stake in the company, which can be viewed as a positive signal.

Stakeholder Impact

• The acquisition of stock options by a director could be perceived positively by shareholders, as it aligns the director's interests with those of the shareholders.

Key Dates